Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of THYROCARE TECHNOLOGIES. For more details, see the THYROCARE TECHNOLOGIES quarterly results and THYROCARE TECHNOLOGIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.5 |
No. of shares | m | 52.95 |
1 Week | % | -0.8 |
1 Month | % | -2.6 |
1 Year | % | 26.3 |
52 week H/L | Rs | 722.0/432.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
THYROCARE TECHNOLOGIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 725 | 689 | 1,212 | 1,466 | 917 | |
Low | Rs | 482 | 407 | 485 | 742 | 416 | |
Sales per share (Unadj.) | Rs | 76.3 | 82.2 | 93.6 | 111.3 | 99.5 | |
Earnings per share (Unadj.) | Rs | 16.1 | 16.7 | 21.4 | 33.3 | 12.2 | |
Diluted earnings per share | Rs | 16.1 | 16.7 | 21.4 | 33.3 | 12.2 | |
Cash flow per share (Unadj.) | Rs | 21.1 | 22.8 | 27.1 | 39.7 | 19.5 | |
Dividends per share (Unadj.) | Rs | 20.00 | 5.00 | 25.00 | 15.00 | 18.00 | |
Adj. dividends per share | Rs | 19.94 | 4.99 | 24.96 | 14.99 | 17.99 | |
Avg Dividend yield | % | 3.3 | 0.9 | 2.9 | 1.4 | 2.7 | |
Book value per share (Unadj.) | Rs | 81.7 | 68.7 | 80.3 | 98.9 | 100.1 | |
Adj. book value per share | Rs | 81.4 | 68.5 | 80.1 | 98.8 | 100.0 | |
Shares outstanding (eoy) | m | 52.80 | 52.83 | 52.87 | 52.90 | 52.93 | |
Price / Sales ratio | x | 7.9 | 6.7 | 9.1 | 9.9 | 6.7 | |
Avg P/E ratio | x | 37.4 | 32.8 | 39.7 | 33.2 | 54.8 | |
P/CF ratio (eoy) | x | 28.6 | 24.1 | 31.3 | 27.8 | 34.2 | |
Price / Book Value ratio | x | 7.4 | 8.0 | 10.6 | 11.2 | 6.7 | |
Dividend payout | % | 124.0 | 29.9 | 116.8 | 45.1 | 148.0 | |
Avg Mkt Cap | Rs m | 31,864 | 28,955 | 44,869 | 58,409 | 35,277 | |
Total wages/salary | Rs m | 434 | 489 | 581 | 611 | 1,062 |
THYROCARE TECHNOLOGIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,029 | 4,343 | 4,946 | 5,889 | 5,267 | |
Other income | Rs m | 100 | 67 | 124 | 293 | 84 | |
Total revenues | Rs m | 4,129 | 4,409 | 5,071 | 6,181 | 5,351 | |
Gross profit | Rs m | 1,549 | 1,675 | 1,712 | 2,356 | 1,237 | |
Depreciation | Rs m | 262 | 319 | 303 | 339 | 387 | |
Interest | Rs m | 6 | 19 | 9 | 32 | 48 | |
Profit before tax | Rs m | 1,381 | 1,404 | 1,525 | 2,277 | 886 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 529 | 520 | 393 | 516 | 242 | |
Profit after tax | Rs m | 851 | 884 | 1,132 | 1,761 | 644 | |
Gross profit margin | % | 38.4 | 38.6 | 34.6 | 40.0 | 23.5 | |
Effective tax rate | % | 38.3 | 37.0 | 25.8 | 22.7 | 27.4 | |
Net profit margin | % | 21.1 | 20.4 | 22.9 | 29.9 | 12.2 |
THYROCARE TECHNOLOGIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,173 | 1,211 | 2,001 | 4,208 | 3,468 | |
Current liabilities | Rs m | 206 | 817 | 951 | 2,153 | 1,509 | |
Net working cap to sales | % | 24.0 | 9.1 | 21.2 | 34.9 | 37.2 | |
Current ratio | x | 5.7 | 1.5 | 2.1 | 2.0 | 2.3 | |
Inventory Days | Days | 102 | 94 | 105 | 164 | 218 | |
Debtors Days | Days | 1 | 1 | 3 | 6 | 6 | |
Net fixed assets | Rs m | 3,336 | 3,166 | 2,997 | 4,271 | 4,881 | |
Share capital | Rs m | 528 | 528 | 529 | 529 | 529 | |
"Free" reserves | Rs m | 3,784 | 3,101 | 3,715 | 4,702 | 4,768 | |
Net worth | Rs m | 4,312 | 3,629 | 4,243 | 5,231 | 5,298 | |
Long term debt | Rs m | 25 | 25 | 0 | 0 | 0 | |
Total assets | Rs m | 4,696 | 4,689 | 5,402 | 8,478 | 8,348 | |
Interest coverage | x | 227.3 | 76.9 | 176.3 | 71.9 | 19.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.9 | 0.9 | 0.7 | 0.6 | |
Return on assets | % | 18.3 | 19.2 | 21.1 | 21.2 | 8.3 | |
Return on equity | % | 19.7 | 24.4 | 26.7 | 33.7 | 12.1 | |
Return on capital | % | 32.0 | 38.9 | 36.1 | 44.1 | 17.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 1.2 | 0.8 | 0.7 | 1.0 | 0.7 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 50 | 35 | 33 | 59 | 36 | |
Fx inflow | Rs m | 52 | 61 | 52 | 7 | 38 | |
Fx outflow | Rs m | 50 | 35 | 33 | 59 | 36 | |
Net fx | Rs m | 2 | 26 | 18 | -52 | 2 |
THYROCARE TECHNOLOGIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,003 | 1,679 | 1,147 | 1,134 | 1,293 | |
From Investments | Rs m | -116 | 10 | -487 | -236 | -390 | |
From Financial Activity | Rs m | -936 | -1,648 | -616 | -894 | -862 | |
Net Cashflow | Rs m | -49 | 41 | 45 | 4 | 41 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: A Velumani | COMP SEC: Ramjee Dorai | YEAR OF INC: 2000 | BSE CODE: 539871 | FV (Rs): 10 | DIV YIELD (%): 2.9 |
Read: THYROCARE TECHNOLOGIES 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare THYROCARE TECHNOLOGIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.